Peptides are chains of amino acids. This directory organises the names found in the peptide section of the supplied document and links to existing substance articles, with separate entries for derivatives and names needing further identification.
More individual substance guides
BPC-157: recovery claims and human evidence
Read article →TB-500TB-500: how it differs from thymosin beta-4
Read article →GHRP-2GHRP-2: GH stimulation and laboratory meaning
Read article →GHRP-6GHRP-6: evidence on growth hormone release
Read article →HexarelinHexarelin: GH evidence and interpretation
Read article →SurvodutideSurvodutide: weight research and health outcomes
Read article →MazdutideMazdutide: GLORY trials and weight evidence
Read article →GonadorelinGonadorelin: GnRH and fertility research
Read article →AHK-CuAHK-Cu: hair research and the GHK-Cu distinction
Read article →ThymalinThymalin: immune research and longevity limits
Read article →Peptide benefits depend on the medicine and indication
Peptides are a diverse molecular group. One established example is Wegovy (semaglutide) for a cardiovascular indication in adults with established cardiovascular disease and overweight or obesity, alongside diet and activity. This is evidence for that medicine and population, not all peptides. Gastrointestinal adverse effects can occur. Use the directory below to read about individual substances.
This directory covers 56 names and forms from pages 1–8 of the source document. It describes substances; individual product identity and medicine status depend on the exact formulation and brand.
Incretin and amylin families
Semaglutide
A GLP-1 receptor agonist peptide. The active substance, salt forms and individual branded products require separate identification. Read more
Tirzepatide
A peptide acting at GIP and GLP-1 receptors, distinguishing it from semaglutide at the receptor level. Read more
Retatrutide
A peptide studied at GIP, GLP-1 and glucagon receptors. It is not currently a component of an FDA-approved drug. Read more Source
Cagrilintide
An amylin analogue, distinct from semaglutide. It is not currently a component of an FDA-approved drug. Read more Source
Survodutide
A GLP-1/glucagon receptor agonist studied in the phase 3 SYNCHRONIZE-1 trial reported in 2026. The trial does not authenticate same-name vials in the document. Source
Mazdutide
A GLP-1/glucagon receptor agonist. Its developer reports product approvals in China; these do not establish Thai registration of the PDF entry. Source
GHRH and GHRP families
Tesamorelin
A GHRH analogue with its own structure and product evidence, distinct from sermorelin and ipamorelin. Read more
Ipamorelin
A growth hormone secretagogue peptide, molecularly distinct from HGH. Read more
Sermorelin
A peptide based on the GHRH(1-29) segment, with evidence distinct from tesamorelin and CJC-1295. Read more
CJC-1295 with DAC
The DAC-labelled entry must be distinguished from the without-DAC entry; CJC-1295 alone is an incomplete form description. Read more
CJC-1295 without DAC
The PDF name for a without-DAC form. Molecular documentation is needed; the name does not establish equivalence to CJC-1295 with DAC. Read more
GHRP-2 Acetate
A synthetic GH-releasing peptide with human hormone-response studies; it is distinct from GHRP-6. Source
GHRP-6 Acetate
A distinct peptide from GHRP-2 and hexarelin, despite belonging to the same broader GHRP family. Source
Hexarelin Acetate
Also called examorelin, a synthetic peptide related to GHRP-6; it is not a finished HGH product. Source
Signalling peptides and derivatives
BPC-157
A 15-amino-acid peptide, distinct from TB-500 and requiring separate interpretation of evidence. Read more
TB-500 / Thymosin B4 Acetate
The PDF pairs TB500 with Thymosin B4 Acetate. Sequence identity needs checking because TB-500 and thymosin beta-4 naming varies by context. Read more
GHK-Cu
A copper complex of the GHK peptide, distinct from AHK-Cu and copper-free GHK. Read more
AHK-Cu
A copper complex of the AHK peptide. Its initial A differs from the G in GHK-Cu, identifying a different peptide. Source
SNAP-8
A name associated with acetyl octapeptide-3. A matching table name does not identify a finished formulation or authenticate its ingredient manufacturer. Source
KPV
A short Lys-Pro-Val tripeptide, distinct from formulations that contain KPV as one component. Read more
AOD-9604
A peptide derivative related to the terminal region of growth hormone, distinguished from full-length HGH and HGH Fragment 176-191. Read more
HGH Fragment 176-191
A name identifying an HGH amino-acid segment. It should not substitute for full-length HGH or establish AOD-9604 identity from an abbreviated label. Read more
Mitochondrial peptides and neuropeptides
MOTS-c
A mitochondria-associated peptide. Endogenous biology and product-level evidence need separate interpretation. Read more
SS-31
A code name for elamipretide, a synthetic peptide studied in relation to mitochondria. Read more
Selank
A synthetic peptide investigated in neurological research, distinct from Semax. Read more
Semax
A synthetic peptide related to an ACTH segment, with a separate identity and research record from Selank. Read more
DSIP
Short for delta sleep-inducing peptide. Its historical name is not proof that a product treats insomnia. Read more
Humanin
A mitochondria-associated peptide; native humanin and study-specific analogues are distinct. Read more
VIP
Short for vasoactive intestinal peptide, a signalling peptide investigated across several body systems. Read more
PE 22-28
A spadin-derived peptide investigated at the TREK-1 ion channel in cellular and animal experiments. Source
Pinealon
A short Glu-Asp-Arg peptide with cellular research, distinct from epithalon. Read more
Dermorphin
An opioid peptide acting at opioid receptors, requiring a clear distinction from cosmetic peptides or ordinary nutrients. Source
Immune-related and cellular research peptides
Thymosin Alpha-1
Also called thymalfasin, a distinct entry from thymalin and thymosin beta-4. Read more
LL-37
A cathelicidin-family peptide associated with innate immunity. Substance-level evidence does not certify the document’s vials. Read more
PNC-27
A peptide investigated in cancer-cell models; cellular findings do not establish cancer treatment in humans. Read more
ARA-290
A code name for cibinetide, a peptide derivative studied separately from full-length erythropoietin. Read more
Glutathione
A tripeptide composed of three amino-acid residues, so it belongs to the peptide class even when listed with other types of compounds. Read more
Short peptides and document names
Epithalon
Also spelled Epitalon; an Ala-Glu-Asp-Gly peptide, distinct from Pinealon and melatonin. Read more
Testagen
A short Lys-Glu-Asp-Gly peptide studied at the cellular level. The name does not mean testosterone. Source
Cardiogen
A distinct entry on document page 5, separate from Cortagen. The file supplies neither its sequence nor research documentation for that vial.
Cortagen
An Ala-Glu-Asp-Pro peptide studied for gene-expression changes in mice, distinct from Cardiogen. Source
Ovagen
Listed as a separate Ovagen entry. The document establishes the listed name but does not provide its amino-acid sequence.
Vesugen
The document separates Vesugen from Ovagen and other entries; these names are retained separately.
Chonluten
The Chonluten spelling is retained from the document. Molecular documentation is needed before substituting a similar name.
Cartalax
A separate document entry from Cardiogen and Cortagen, without an attached physical label or batch analysis.
Pancragen
Listed separately as Pancragen. The name alone does not establish product properties or organ-specific outcomes.
Peptide hormones and names to distinguish
PT-141
A code name for bremelanotide, a peptide derivative distinguished from brand names and finished-product formulations. Read more
Gonadorelin Acetate
Gonadorelin is a GnRH peptide; acetate in the document identifies a salt form. Source
Kisspeptin-10
A 10-residue kisspeptin segment, distinguished from other kisspeptin forms. Read more
Oxytocin Acetate
The peptide hormone oxytocin; acetate form and product details supplement the substance name. Read more
Melanotan 1
The document’s name, separate from Melanotan 2 and from non-peptide melatonin. This spelling alone does not identify a branded medicine.
Melanotan 2
Also written Melanotan II, distinct from Melanotan 1 and melatonin. Read more
Cerebrolysin
A name associated with a peptide mixture rather than a single defined peptide sequence. The PDF entry is distinct from specifically registered products. Read more
Thymalin
The document uses Thymalin, separately from thymosin alpha-1; it lacks detailed composition establishing any equivalence.
PEG-MGF
A name for PEG-modified mechano growth factor, distinct from IGF-1 LR3. FDA identifies insufficient human information for safety assessment. Source
FOXO4 — document name
The document says FOXO4 without specifying FOXO4-DRI or a molecular sequence. Its original name is retained without assigning a particular derivative.
Frequently asked questions
Does a peptide name identify a brand?
No. A substance name identifies a molecule or research name. A specific product also needs a matching manufacturer, formulation and label.
Are CJC-1295 with DAC and without DAC the same listing?
They are separate entries in the document. The DAC designation and molecular identity should be preserved when comparing information.
Are GHK-Cu and AHK-Cu the same peptide?
No. They refer to different copper-peptide names and should have separate records.
Why is NAD+ not in this peptide directory?
NAD+ is a coenzyme, not a peptide. Solvents, non-peptide compounds, tablets and steroid products were also excluded from this selection.
Does a research result apply to every same-name vial?
No. Study evidence describes the tested material and context. A document entry does not establish equivalence to that material or its regulatory status.
For general questions about names and labels: LINE: @musclestationth